2025 annual financial data
Korro Bio 2025 Operating margin
Direct answer
Operating margin was -1,366.43%.
Operating income was -87,342,000 USD and net income was -117,260,000 USD.
Operating cash flow was -78,561,000 USD.
Get free Korro Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 6,392,000 USD
- Operating income
- -87,342,000 USD
- Net income
- -117,260,000 USD
- Operating cash flow
- -78,561,000 USD